Wanying Lu
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Social contact patterns and their impact on the transmission of respiratory pathogens in rural China.
Journal: Infectious Disease Modelling
Published: October 11, 2024
Heterogeneous changes in mobility in response to the SARS-CoV-2 Omicron BA.2 outbreak in Shanghai.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: October 12, 2023
Transplacental transfer efficiency of maternal antibodies against influenza A(H1N1)pdm09 virus and dynamics of naturally acquired antibodies in Chinese children: a longitudinal, paired mother-neonate cohort study.
Journal: The Lancet. Microbe
Published: December 03, 2022
Modeling transmission of SARS-CoV-2 Omicron in China.
Journal: Nature medicine
Published: March 22, 2022
Six-month follow-up of a booster dose of CoronaVac in two single-centre phase 2 clinical trials.
Journal: Nature communications
Published: January 24, 2022
Prediction of long-term kinetics of vaccine-elicited neutralizing antibody and time-varying vaccine-specific efficacy against the SARS-CoV-2 Delta variant by clinical endpoint.
Journal: BMC medicine
Published: October 07, 2021
Global landscape of SARS-CoV-2 genomic surveillance, public availability extent of genomic data, and epidemic shaped by variants.
Journal: Research square
Published: October 06, 2021
Global landscape of SARS-CoV-2 genomic surveillance and data sharing.
Journal: Nature genetics
Published: September 22, 2021
Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials.
Journal: The Lancet. Infectious diseases
Published: September 15, 2021
Prediction of vaccine efficacy of the Delta variant.
Journal: medRxiv : the preprint server for health sciences
Published: September 08, 2021
Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants Induced by Natural Infection or Vaccination: A Systematic Review and Pooled Analysis.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: June 04, 2021
Last Updated: 09/26/2026